PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
06-Nov-2024 England and Wales fertility rate falls to lowest on record. Is that by choice, asks expert? London Medical Laboratory
05-Nov-2024 Leading digital insights consultancy, Creation Healthcare, and largest online global physician community, G-Med, announce historic partnership enabling comparative analysis of online conversations of millions of HCPs worldwide Creation Healthcare
04-Nov-2024 New analysis uncovers significant decrease in mental health staffing during austerity University of East Anglia
01-Nov-2024 The Howard de Walden Estate invests £52m in new HealthTech development as part of healthcare evolution The Howard de Walden Estate
01-Nov-2024 Latest Innovation Scorecard for the NHS in England published by the NHSBSA The NHS Business Services Authority (NHSBSA)
31-Oct-2024 TOPVISION Transfers From LEAP Market To ACE Market, Signs Underwriting Agreement With Hong Leong Investment Bank TOPVISION Eye Specialist Berhad
29-Oct-2024 Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics Medidata
29-Oct-2024 TREMFYA® (Guselkumab) is the first IL-23 inhibitor to demonstrate robust results with a fully subcutaneous regimen in both induction and maintenance in Crohn’s disease JOHNSON & JOHNSON
29-Oct-2024 ASTRAZENCA SECURES ACCELERATED NICE RECOMMENDATION FOR WAINZUA™▼(EPLONTERSEN) in ENGLAND AND WALES FOLLOWING MHRA LICENCE TO TREAT HEREDITARY TRANSTHYRETIN AMYLOIDOSIS IN ADULT PATIENTS WITH STAGE 1 OR 2 POLYNEUROPATHY AstraZeneca
28-Oct-2024 Almirall´s 2024 Immunoskin conference hosts leading experts in inflammatory skin conditions to advance science and treatment options Almirall
28-Oct-2024 UPM Biomedicals launches FibGel™ the world’s first injectable nanocellulose hydrogel for medical devices UPM Biomedicals
28-Oct-2024 Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis AstraZeneca
28-Oct-2024 ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement ProQR
28-Oct-2024 Aston Institute for Membrane Excellence holds business showcase with Arup and Bruntwood SciTech in Birmingham Tech Week Aston Institute for Membrane Excellence
28-Oct-2024 Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance Sanofi
28-Oct-2024 Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule Orion Corporation
28-Oct-2024 Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI Regeneron
28-Oct-2024 England's Health Ombudsman comments on the CQC's State of Care report PHSO
28-Oct-2024 iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress iTeos Therapeutics, Inc
28-Oct-2024 NEW RESEARCH REVEALS LACK OF AWARENESS AROUND ELIGIBILITY FOR WINTER VACCINES Moderna